Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s Hospital Westmead, before moving the MCRI in 2013.
He has almost 15 years of experience in the laboratory where he is working to understand the impact of genetic variants on skeletal muscle performance in health and disease.
His Team now focuses on using stem cells to model and test new treatments for patients with genetic muscle diseases, including Duchenne muscular dystrophy (DMD), Facioscapulohumeral muscular dystrophy (FSHD) and other congenital muscular dystrophies.
Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s...
Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s Hospital Westmead, before moving the MCRI in 2013.
He has almost 15 years of experience in the laboratory where he is working to understand the impact of genetic variants on skeletal muscle performance in health and disease.
His Team now focuses on using stem cells to model and test new treatments for patients with genetic muscle diseases, including Duchenne muscular dystrophy (DMD), Facioscapulohumeral muscular dystrophy (FSHD) and other congenital muscular dystrophies.
Top Publications
Knights, AJ, Vohralik, EJ, Houweling, PJ, Stout, ES, Norton, LJ, Alexopoulos, SJ, Yik, JJ, Mat Jusoh, H, Olzomer, EM, Bell-Anderson, KS, et al.
Eosinophil function in adipose tissue is regulated by Krüppel-like factor 3 (KLF3).
Nature Communications
11(1)
:
2922
2024
view publication
Vasiljevski, ER, Houweling, PJ, Rupasinghe, T, Kaur, T, Summers, MA, Roessner, U, Little, DG, Schindeler, A.
Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
PLOS ONE
15(8)
:
e0237097
2024
view publication
Seto, JT, Roeszler, KN, Meehan, LR, Wood, HD, Tiong, C, Bek, L, Lee, SF, Shah, M, Quinlan, KGR, Gregorevic, P, et al.
ACTN3 genotype influences skeletal muscle mass regulation and response to dexamethasone.
2024
view publication
Wyckelsma, V, Venckunas, T, Houweling, P, Schlittler, M, Lauschke, V, Tiong, C, Wood, H, Ivarsson, N, Paulauskas, H, Eimantas, N, et al.
Loss of α-actinin-3 during human evolution provides superior cold resilience and muscle heat generation.
2024
view publication
Kiriaev, L, Kueh, S, Morley, JW, North, KN, Houweling, PJ, Head, SI.
Lifespan analysis of dystrophic mdx fast-twitch muscle morphology and its impact on contractile function.
2024
view publication